PL371295A1 - Hfa-suspension formulation of an anhydrate - Google Patents

Hfa-suspension formulation of an anhydrate

Info

Publication number
PL371295A1
PL371295A1 PL03371295A PL37129503A PL371295A1 PL 371295 A1 PL371295 A1 PL 371295A1 PL 03371295 A PL03371295 A PL 03371295A PL 37129503 A PL37129503 A PL 37129503A PL 371295 A1 PL371295 A1 PL 371295A1
Authority
PL
Poland
Prior art keywords
hfa
anhydrate
suspension formulation
formulation
suspension
Prior art date
Application number
PL03371295A
Other languages
English (en)
Polish (pl)
Inventor
Christel Schmelzer
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co.Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Gmbh & Co.Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co.Kg
Publication of PL371295A1 publication Critical patent/PL371295A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PL03371295A 2002-03-28 2003-03-20 Hfa-suspension formulation of an anhydrate PL371295A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10214264A DE10214264A1 (de) 2002-03-28 2002-03-28 HFA-Suspensionsformulierungen eines Anhydrats

Publications (1)

Publication Number Publication Date
PL371295A1 true PL371295A1 (en) 2005-06-13

Family

ID=28050990

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03371295A PL371295A1 (en) 2002-03-28 2003-03-20 Hfa-suspension formulation of an anhydrate

Country Status (21)

Country Link
EP (1) EP1492498A2 (uk)
JP (1) JP5147158B2 (uk)
KR (1) KR101005717B1 (uk)
CN (1) CN1642525A (uk)
AU (1) AU2003221509B2 (uk)
BR (1) BR0308709A (uk)
CA (1) CA2479638C (uk)
DE (1) DE10214264A1 (uk)
EA (1) EA008610B1 (uk)
EC (1) ECSP045322A (uk)
HR (1) HRP20040890A2 (uk)
IL (1) IL163696A0 (uk)
ME (1) ME00246B (uk)
MX (1) MXPA04009338A (uk)
NO (1) NO20044004L (uk)
NZ (1) NZ536030A (uk)
PL (1) PL371295A1 (uk)
RS (1) RS52481B (uk)
UA (1) UA79776C2 (uk)
WO (1) WO2003082244A2 (uk)
ZA (1) ZA200405637B (uk)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008540367A (ja) * 2005-05-02 2008-11-20 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規結晶性臭化チオトロピウム
WO2006117299A2 (en) * 2005-05-02 2006-11-09 Boehringer Ingelheim International Gmbh Novel crystalline forms of tiotropium bromide
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
AU2015201037C1 (en) * 2009-05-29 2017-07-27 Pearl Therapeutics, Inc. Respiratory delivery of active agents
PL3111927T3 (pl) 2009-05-29 2020-06-29 Pearl Therapeutics, Inc. Kompozycje do wziewnego podawania środków aktywnych oraz związane z nimi sposoby i systemy
SG11201507286QA (en) 2013-03-15 2015-10-29 Pearl Therapeutics Inc Methods and systems for conditioning of particulate crystalline materials
CN114712337A (zh) * 2016-09-19 2022-07-08 墨西哥氟石股份公司 药物组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
JP4672143B2 (ja) * 1998-08-04 2011-04-20 ヤゴテック アーゲー 医薬用エーロゾル製剤
GB0009583D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory formulations
GB0009605D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medicaments
GB0009592D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory combinations
GB0009606D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic combinations
JP2004512379A (ja) * 2000-10-31 2004-04-22 ベーリンガー　インゲルハイム　ファルマ　ゲゼルシャフト　ミット　ベシュレンクテル　ハフツング　ウント　コンパニー　コマンディトゲゼルシャフト 新規医薬組成物
DE10113366A1 (de) * 2001-03-20 2002-09-26 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Endothelinantagonisten
DE10111058A1 (de) * 2001-03-08 2002-09-12 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und NK¶1¶-Rezeptor-Antagonisten

Also Published As

Publication number Publication date
UA79776C2 (en) 2007-07-25
WO2003082244A2 (de) 2003-10-09
MXPA04009338A (es) 2005-01-25
EP1492498A2 (de) 2005-01-05
DE10214264A1 (de) 2003-10-16
AU2003221509A1 (en) 2003-10-13
NZ536030A (en) 2006-07-28
CN1642525A (zh) 2005-07-20
ME00246B (me) 2011-05-10
BR0308709A (pt) 2005-01-04
NO20044004L (no) 2004-10-05
EA008610B1 (ru) 2007-06-29
WO2003082244A3 (de) 2004-02-05
CA2479638A1 (en) 2003-10-09
ECSP045322A (es) 2005-01-28
CA2479638C (en) 2011-01-04
YU86004A (sh) 2006-08-17
HRP20040890A2 (en) 2005-06-30
IL163696A0 (en) 2005-12-18
MEP47308A (en) 2011-02-10
AU2003221509B2 (en) 2008-01-24
JP2005527550A (ja) 2005-09-15
KR101005717B1 (ko) 2011-01-05
ZA200405637B (en) 2005-07-27
JP5147158B2 (ja) 2013-02-20
EA200401159A1 (ru) 2005-04-28
RS52481B (sr) 2013-02-28
KR20040098022A (ko) 2004-11-18

Similar Documents

Publication Publication Date Title
AU154703S (en) Set of trocars
EG23458A (en) Set of elements for assemlying structures
ITMI20021228A1 (it) Composizioni di poliuretani reticolabili
AU2003301451A1 (en) Component capable of being cooled
EP1577280A4 (en) DEUTERATION PROCESS
IL166331A0 (en) 5-arylterazole compounds compositions thereof and uses therefor
GB0207438D0 (en) Formulation
AU2003226487A8 (en) Formulation
AU2003302372A8 (en) Formulations of finasteride
PL372655A1 (en) Compositions of pentafluoropropane
IL163696A0 (en) Hfa-suspension formulation of an anhydrate
GB2388064B (en) Precise positioning of an object
AU2003216848A1 (en) Deracemisation of amines
PL371427A1 (en) New uses of substituted aminoalkanephosphonic acids
AU2003298725A8 (en) Preparation of metallotexaphyrins
AU2003267800A1 (en) Methods of using ccr1 antagonists as immunomodulatory agents
HUP0203929D0 (en) New use of substituted alkyl-piridazinone derivatives
PL356853A1 (en) Application of bacteriphages
IL165356A0 (en) Preparation of 4-haloalkylkylnicotinamides
GB0222015D0 (en) Means of assembly-bozz 2
SI1537210T1 (sl) Lazna oligonukleotidna inhibicija ekspresije CD40
SI1509241T1 (sl) Nove uporabe cefaibolov
EP1511485A4 (en) NOVEL USES OF I DL / I -TETRAHYDROPALMATIN
GB0215591D0 (en) Formulation
GB0215589D0 (en) Formulation

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)